SIPO Biotechnology Co. Ltd.
1 clinical trials · Sponsor
◉ Watch SIPO Biotechnology Co. Ltd.
| Record | Firm | Date |
|---|---|---|
| Preliminary Evaluation of the Safety and Tolerability of SPOT-mRNA01 Subcutaneously Administered in Healthy Subjects (NCT06567119) | SIPO Biotechnology Co. Ltd. | 2027-01-11 |
Track SIPO Biotechnology Co. Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.